EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biomimetic Co‐delivery of Lenvatinib and FePt Nanoparticles for Enhanced Ferroptosis/Apoptosis Treatment of Hepatocellular Carcinoma

Feichao Xuan, Xingyang Zhao, Weiran Pang, Zirong Li, Xiangyi Yin, Weizhong Xie, Xiaojun Zeng, Liming Nie, Junying Yang, Shiying Li, Puxiang Lai, Chihua Fang iD

Advanced Healthcare Materials · 2025-04 · 14 (11)

DOI: 10.1002/adhm.202401747 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 21.03.2025. Verfasst von Feichao Xuan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery I, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China. Hauptthemen laut MEDLINE: Ferroptosis, Carcinoma, Hepatocellular, Liver Neoplasms, Apoptosis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hong Kong Polytechnic University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lenvatinib, endorse as a first‐line targeted therapy, has demonstrated efficacy in extending the survival span of individuals afflicted with advanced Hepatocellular carcinoma (HCC). However, its therapeutic effect wears off with time, which is ascribed to the cancer cell's tendency to evade and tamper with its usual modes of action, severely limiting its clinical use. This study devises an innovative therapeutic modality involving the synergistic co‐delivery of FePt nanoparticles (NPs) and Lenvatinib via poly lactic‐co‐glycolic acid (PLGA) NPs encase in HCC cell membranes (Len/FePt@CMP NPs). The investigation explores the mechanism through which Lenvatinib induces ferroptosis in HCC, notably by dampening the glutathione peroxidase 4 (GPX4) through the inhibition of fibroblast growth factor receptor 4. FePt NPs are engineered to enhance the efficacy of ferroptosis and apoptosis for HCC treatment. Concurrently, the incorporation of the cancer cell membrane facilitates the targeted accumulation of NPs at the tumor site, leveraging mechanisms of immune evasion and homologous targeting. This enhances ferroptosis/apoptosis treatment efficacy, triggeres by Len/FePt@CMP NPs, is convincingly demonstrated both in vitro and in vivo. The proposed approach has the potential to redefine HCC therapeutic paradigms by overcoming mono‐therapeutic limitations in current clinical treatments, showcasing the improved efficacy of a comprehensive strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisCarcinoma, HepatocellularLiver NeoplasmsApoptosisQuinolinesPhenylurea CompoundsBiomimetic MaterialsNanoparticlesHumansAnimalsMiceCell Line, TumorAntineoplastic AgentsPolylactic Acid-Polyglycolic Acid CopolymerMice, NudeMice, Inbred BALB CBiomimetics

Stichwörter der Autor:innen

Lenvatinibapoptosiscancer cell membrane coated nanoparticlescombined therapyferroptosishepatocellular carcinoma

Substanzen

lenvatinibQuinolinesPhenylurea CompoundsAntineoplastic AgentsPolylactic Acid-Polyglycolic Acid Copolymer

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery I, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China.
  • Department of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, 999077, China.
  • Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.

ORCID-Profile: Chihua Fang

Förderung

  • National Natural Science Foundation of China
  • Hong Kong Polytechnic University

Zitieren

APA

Xuan, F., Zhao, X., Pang, W., Li, Z., Yin, X., Xie, W., Zeng, X., Nie, L., Yang, J., Li, S., Lai, P., & Fang, C. (2025). Biomimetic Co‐delivery of Lenvatinib and FePt Nanoparticles for Enhanced Ferroptosis/Apoptosis Treatment of Hepatocellular Carcinoma. Advanced Healthcare Materials, 14(11). https://doi.org/10.1002/adhm.202401747

Vancouver

Xuan F, Zhao X, Pang W, Li Z, Yin X, Xie W, et al. Biomimetic Co‐delivery of Lenvatinib and FePt Nanoparticles for Enhanced Ferroptosis/Apoptosis Treatment of Hepatocellular Carcinoma. Advanced Healthcare Materials. 2025;14(11). doi:10.1002/adhm.202401747

BibTeX
@article{Xuan2025,
  author = {Xuan, Feichao and Zhao, Xingyang and Pang, Weiran and Li, Zirong and Yin, Xiangyi and Xie, Weizhong and Zeng, Xiaojun and Nie, Liming and Yang, Junying and Li, Shiying and Lai, Puxiang and Fang, Chihua},
  title = {Biomimetic Co‐delivery of Lenvatinib and FePt Nanoparticles for Enhanced Ferroptosis/Apoptosis Treatment of Hepatocellular Carcinoma},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {11},
  doi = {10.1002/adhm.202401747}
}
Kostenlos starten →